A citation-based method for searching scientific literature


List of co-cited articles
329 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS.
Stéphane Bouchet, Emmanuelle Chauzit, Dominique Ducint, Nadège Castaing, Mireille Canal-Raffin, Nicholas Moore, Karine Titier, Mathieu Molimard. Clin Chim Acta 2011
119
48

Development and clinical application of a LC-MS/MS method for simultaneous determination of various tyrosine kinase inhibitors in human plasma.
Lutz Götze, Axel Hegele, Stephan Klaus Metzelder, Harald Renz, Wolfgang Andreas Nockher. Clin Chim Acta 2012
67
39

An automated method for the measurement of a range of tyrosine kinase inhibitors in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry.
L Couchman, M Birch, R Ireland, A Corrigan, S Wickramasinghe, D Josephs, J Spicer, R J Flanagan. Anal Bioanal Chem 2012
53
49


Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
A Haouala, B Zanolari, B Rochat, M Montemurro, K Zaman, M A Duchosal, H B Ris, S Leyvraz, N Widmer, L A Decosterd. J Chromatogr B Analyt Technol Biomed Life Sci 2009
139
34

A validated assay for the simultaneous quantification of six tyrosine kinase inhibitors and two active metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
Nielka P van Erp, Djoeke de Wit, Henk-Jan Guchelaar, Hans Gelderblom, Trees J Hessing, Jan den Hartigh. J Chromatogr B Analyt Technol Biomed Life Sci 2013
57
33

Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry.
R Honeywell, K Yarzadah, E Giovannetti, N Losekoot, E F Smit, M Walraven, J S W Lind, C Tibaldi, H M Verheul, G J Peters. J Chromatogr B Analyt Technol Biomed Life Sci 2010
65
24

Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets.
Huixin Yu, Neeltje Steeghs, Cynthia M Nijenhuis, Jan H M Schellens, Jos H Beijnen, Alwin D R Huitema. Clin Pharmacokinet 2014
153
22


New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.
Silvia De Francia, Antonio D'Avolio, Francesca De Martino, Elisa Pirro, Lorena Baietto, Marco Siccardi, Marco Simiele, Silvia Racca, Giuseppe Saglio, Francesco Di Carlo,[...]. J Chromatogr B Analyt Technol Biomed Life Sci 2009
72
16

A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients.
Elisa Pirro, Silvia De Francia, Francesca De Martino, Carmen Fava, Stefano Ulisciani, Giovanna Rege Cambrin, Silvia Racca, Giuseppe Saglio, Francesco Di Carlo. J Chromatogr Sci 2011
27
40

Simple methodology for the therapeutic drug monitoring of the tyrosine kinase inhibitors dasatinib and imatinib.
M Birch, P E Morgan, S Handley, A Ho, R Ireland, R J Flanagan. Biomed Chromatogr 2013
24
45

Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies.
Nicolas Widmer, Christophe Bardin, Etienne Chatelut, Angelo Paci, Jos Beijnen, Dominique Levêque, Gareth Veal, Alain Astier. Eur J Cancer 2014
191
16


Clinical pharmacokinetics of tyrosine kinase inhibitors.
Nielka P van Erp, Hans Gelderblom, Henk-Jan Guchelaar. Cancer Treat Rev 2009
289
13



Simultaneous determination of nilotinib, imatinib and its main metabolite (CGP-74588) in human plasma by ultra-violet high performance liquid chromatography.
Andrea Davies, Alison K Hayes, Katy Knight, Sarah J Watmough, Munir Pirmohamed, Richard E Clark. Leuk Res 2010
38
23

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study.
Richard A Larson, Brian J Druker, Francois Guilhot, Stephen G O'Brien, Gilles J Riviere, Tillmann Krahnke, Insa Gathmann, Yanfeng Wang. Blood 2008
462
12


Evidence for therapeutic drug monitoring of targeted anticancer therapies.
Bo Gao, Shang Yeap, Arthur Clements, Bavanthi Balakrishnar, Mark Wong, Howard Gurney. J Clin Oncol 2012
142
12

Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Patton Minkin, Ming Zhao, Zhaoyuan Chen, Jan Ouwerkerk, Hans Gelderblom, Sharyn D Baker. J Chromatogr B Analyt Technol Biomed Life Sci 2008
47
17

An HPLC-UV method for the simultaneous quantification of vemurafenib and erlotinib in plasma from cancer patients.
Yi Zhen, Audrey Thomas-Schoemann, Lilia Sakji, Pascaline Boudou-Rouquette, Nicolas Dupin, Laurent Mortier, Michel Vidal, Francois Goldwasser, Benoit Blanchet. J Chromatogr B Analyt Technol Biomed Life Sci 2013
27
25

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia.
Stephane Picard, Karine Titier, Gabriel Etienne, Emmanuelle Teilhet, Dominique Ducint, Marie-Agnes Bernard, Regis Lassalle, Gerald Marit, Josy Reiffers, Bernard Begaud,[...]. Blood 2007
450
10

A simple HPLC-UV method for the simultaneous quantification of gefitinib and erlotinib in human plasma.
Lionel Faivre, Charline Gomo, Olivier Mir, Fabrice Taieb, Audrey Schoemann-Thomas, Stanislas Ropert, Michel Vidal, Daniel Dusser, Alain Dauphin, Francois Goldwasser,[...]. J Chromatogr B Analyt Technol Biomed Life Sci 2011
48
14



A new rapid and sensitive LC-MS assay for the determination of sorafenib in plasma: application to a patient undergoing hemodialysis.
Christine Bobin-Dubigeon, Alexandra Heurgue-Berlot, Olivier Bouché, Marie-Bernadette Amiand, Chantal Le Guellec, Jean-Marie Bard. Ther Drug Monit 2011
12
58

Sunitinib LC-MS/MS Assay in Mouse Plasma and Brain Tissue: Application in CNS Distribution Studies.
Rajneet K Oberoi, Rajendar K Mittapalli, James Fisher, William F Elmquist. Chromatographia 2013
20
35

A method to quantify several tyrosine kinase inhibitors in plasma by micellar liquid chromatography and validation according to the European Medicines Agency guidelines.
Iris Garrido-Cano, Aurelio García-García, Juan Peris-Vicente, Enrique Ochoa-Aranda, Josep Esteve-Romero. Talanta 2015
18
38

Quantification of 11 Therapeutic Kinase Inhibitors in Human Plasma for Therapeutic Drug Monitoring Using Liquid Chromatography Coupled With Tandem Mass Spectrometry.
Maikel Herbrink, Niels de Vries, Hilde Rosing, Alwin D R Huitema, Bastiaan Nuijen, Jan H M Schellens, Jos H Beijnen. Ther Drug Monit 2016
33
21

Development and Validation of a Simultaneous Quantification Method of 14 Tyrosine Kinase Inhibitors in Human Plasma Using LC-MS/MS.
Huu H Huynh, Claire Pressiat, Hélène Sauvageon, Isabelle Madelaine, Patricia Maslanka, Céleste Lebbé, Catherine Thieblemont, Lauriane Goldwirt, Samia Mourah. Ther Drug Monit 2017
54
12

High throughput routine determination of 17 tyrosine kinase inhibitors by LC-MS/MS.
Camille Merienne, Marine Rousset, Dominique Ducint, Nadège Castaing, Karine Titier, Mathieu Molimard, Stéphane Bouchet. J Pharm Biomed Anal 2018
55
12


Moving towards dose individualization of tyrosine kinase inhibitors.
Heinz-Josef Klümpen, Caroline F Samer, Ron H J Mathijssen, Jan H M Schellens, Howard Gurney. Cancer Treat Rev 2011
83
9

High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid.
Werner J Heinz, Kathrin Kahle, Annegret Helle-Beyersdorf, Diana Schirmer, Ulrike Lenker, Daniela Keller, Peter Langmann, Hartwig Klinker. Cancer Chemother Pharmacol 2011
27
22


High-performance liquid chromatographic assay for the determination of nilotinib in human plasma.
Misato Yuki, Yuji Yamakawa, Takashi Uchida, Takeru Nambu, Tatsuya Kawaguchi, Akinobu Hamada, Hideyuki Saito. Biol Pharm Bull 2011
12
50

A routine feasible HPLC analysis for the anti-angiogenic tyrosine kinase inhibitor, sunitinib, and its main metabolite, SU12662, in plasma.
Marie-Christine Etienne-Grimaldi, Nicole Renée, Hassan Izzedine, Gérard Milano. J Chromatogr B Analyt Technol Biomed Life Sci 2009
30
20


HPLC-DAD protein kinase inhibitor analysis in human serum.
Marek Dziadosz, Rüdiger Lessig, Heidemarie Bartels. J Chromatogr B Analyt Technol Biomed Life Sci 2012
23
26

Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometry.
Lie Li, Ming Zhao, Fariba Navid, Keith Pratz, B Doug Smith, Michelle A Rudek, Sharyn D Baker. J Chromatogr B Analyt Technol Biomed Life Sci 2010
45
13


Determination of imatinib and its active metabolite N-desmethyl imatinib in human plasma by liquid chromatography/tandem mass spectrometry.
Mei Zhang, Grant A Moore, Liam J Fernyhough, Murray L Barclay, Evan J Begg. Anal Bioanal Chem 2012
8
75

LC-MS-MS determination of imatinib and N-desmethyl imatinib in human plasma.
Yunjing Zhang, Shuping Qiang, Zhi Yu, Weiwei Zhang, Zhongnan Xu, Lin Yang, Aidong Wen, Taijun Hang. J Chromatogr Sci 2014
20
30

Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry.
Eva Kralj, Jurij Trontelj, Tadej Pajič, Albin Kristl. J Chromatogr B Analyt Technol Biomed Life Sci 2012
44
13

Imatinib assay by HPLC with photodiode-array UV detection in plasma from patients with chronic myeloid leukemia: Comparison with LC-MS/MS.
Olivia Roth, Odile Spreux-Varoquaux, Stephane Bouchet, Philippe Rousselot, Sylvie Castaigne, Sophie Rigaudeau, Victoria Raggueneau, Patrice Therond, Philippe Devillier, Mathieu Molimard,[...]. Clin Chim Acta 2010
42
14


Plasma concentrations of tyrosine kinase inhibitors imatinib, erlotinib, and sunitinib in routine clinical outpatient cancer care.
Nienke A G Lankheet, Lotte M Knapen, Jan H M Schellens, Jos H Beijnen, Neeltje Steeghs, Alwin D R Huitema. Ther Drug Monit 2014
69
9

Recent developments in the chromatographic bioanalysis of approved kinase inhibitor drugs in oncology.
Johannes J M Rood, Jan H M Schellens, Jos H Beijnen, Rolf W Sparidans. J Pharm Biomed Anal 2016
24
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.